Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate.
Sciot R, Debiec-Rychter M, Daugaard S, Fisher C, Collin F, van Glabbeke M, Verweij J, Blay JY, Hogendoorn PC; EORTC Soft Tissue and Bone Sarcoma Group; Italian Sarcoma Group; Australasian Trials Group. Sciot R, et al. Among authors: daugaard s. Eur J Cancer. 2008 Sep;44(13):1855-60. doi: 10.1016/j.ejca.2008.06.003. Epub 2008 Jul 22. Eur J Cancer. 2008. PMID: 18653326 Clinical Trial.
Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment.
Hogendoorn PC, Collin F, Daugaard S, Dei Tos AP, Fisher C, Schneider U, Sciot R; Pathology and Biology Subcommittee of the EORTC Soft Tissue and Bone Sarcoma Group. Hogendoorn PC, et al. Among authors: daugaard s. Eur J Cancer. 2004 Jul;40(11):1644-54. doi: 10.1016/j.ejca.2004.04.004. Eur J Cancer. 2004. PMID: 15251152 Review.
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.
Young RJ, Litière S, Lia M, Hogendoorn PCW, Fisher C, Mechtersheimer G, Daugaard S, Sciot R, Collin F, Messiou C, Grünwald V, Gronchi A, van der Graaf W, Wardelmann E, Judson I. Young RJ, et al. Among authors: daugaard s. Acta Oncol. 2017 Jul;56(7):1013-1020. doi: 10.1080/0284186X.2017.1315173. Epub 2017 Apr 21. Acta Oncol. 2017. PMID: 28431480 Free article. Clinical Trial.
Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
van Oosterwijk JG, Meijer D, van Ruler MA, van den Akker BE, Oosting J, Krenács T, Picci P, Flanagan AM, Liegl-Atzwanger B, Leithner A, Athanasou N, Daugaard S, Hogendoorn PC, Bovée JV. van Oosterwijk JG, et al. Among authors: daugaard s. Am J Pathol. 2013 Apr;182(4):1347-56. doi: 10.1016/j.ajpath.2012.12.036. Epub 2013 Feb 15. Am J Pathol. 2013. PMID: 23415961 Free article.
Local control and survival in patients with soft tissue sarcomas treated with limb sparing surgery in combination with interstitial brachytherapy and external radiation.
Muhic A, Hovgaard D, Mørk Petersen M, Daugaard S, Højlund Bech B, Roed H, Kjaer-Kristoffersen F, Aage Engelholm S. Muhic A, et al. Among authors: daugaard s. Radiother Oncol. 2008 Sep;88(3):382-7. doi: 10.1016/j.radonc.2008.06.002. Epub 2008 Jun 26. Radiother Oncol. 2008. PMID: 18584905
Primary cardiac tumors: a clinicopathologic evaluation of four cases.
Winther C, Timmermans-Wielenga V, Daugaard S, Mortensen SA, Sander K, Andersen CB. Winther C, et al. Among authors: daugaard s. Cardiovasc Pathol. 2011 Jan-Feb;20(1):63-7. doi: 10.1016/j.carpath.2009.11.004. Epub 2010 Jan 8. Cardiovasc Pathol. 2011. PMID: 20060324
YKL-40 protein in osteosarcoma tumor tissue.
Thorn AP, Daugaard S, Christensen LH, Christensen IJ, Petersen MM. Thorn AP, et al. Among authors: daugaard s. APMIS. 2016 Jun;124(6):453-61. doi: 10.1111/apm.12524. Epub 2016 Mar 14. APMIS. 2016. PMID: 26988273
88 results